주메뉴 바로가기

본문 바로가기

연구개발

녹십자랩셀은 지속적으로 해외 유명 학술지에 우수한
연구 결과를 발표하며 세계 석학들과 어깨를 나란히 하고 있습니다.

  • GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo
    저자 Lim O et al. 학술지명 PLoS One. 2013 ; 8(1) : e53611
  • Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors
    저자 Yang Y et al. 학술지명 Cancer Immunol Res. 2016 Mar ; 4(3) : 215-24
  • Natural Killer (NK) Cells Inhibit Systemic Metastasis of Glioblastoma Cells and have Therapeutic Effects Against Glioblastomas in the Brain
    저자 Lee SJ et al. 학술지명 BMC Cancer. 2015 ; 15 : 1011
  • Present and Future of Allogeneic Natural Killer Cell Therapy.
    저자 Lim O et al. 학술지명 Front Immunol. 2015 Jun 3 ; 6 : 286
  • Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell.
    저자 Bae DS et al. 학술지명 Cell Immunol. 2012 Mar-Apr ; 276(1-2) : 122-7
  • Enhancing T Cell Immune Responses by B Cell-based Therapeutic Vaccine Against Chronic Virus Infection.
    저자 Kim MK et al. 학술지명 Immune Netw. 2014 Aug ; 14(4) : 207-18